Bitcoin Slides Below 77000 as US Strikes on Iran Intensify Geopolitical Risk and ETF Outflows Mount AST SpaceMobile and Rocket Lab A Comparative Look at Two Space Stocks for 2026 Beyond Inc Acquires Buy Buy Baby Brand Rights Reuniting With Bed Bath Beyond AI Semiconductor Futures Set to Launch on CME Groups Compute Market SpaceX Postpones Starship Launch Amid Anticipated Mega Share Sale ConocoPhillips Cash Flow Focus Remains Key Amid LNG Development Activity Champions Oncology CSBR Q1 2026 Earnings EPS Misses by Wide Margin as Company Posts Loss International Seaways INSW Q1 2026 Earnings Earnings Beat by 476 as Tanker Market Remains Favorable MRSH Q1 2026 Earnings EPS Slightly Misses Estimates Amid Stable Operations UL Solutions Inc ULS Q1 2026 Earnings Strong Profit Beat Amid Solid Operational Execution GLXY Q1 2026 Earnings EPS Misses Estimates Amid Crypto Market Volatility SVCO Q1 2026 Earnings EPS Surpasses Estimates Stock Gains 274 Parke Bancorp Inc PKBK Hovers Near Flatline as Traders Weigh Support and Resistance Levels MoneyHero Limited Warrants MNYWW Sink 6 to 005 MicroCap Warrant in Tight Range Viewbix Inc VBIX Holds Steady at 364 as Trading Range Tightens Greenbrier Companies GBX Hovers Near Resistance Amid Minimal Gains What Lies Ahead Tantech Holdings TANH Edges Higher at 041 as Support Holds UK Chancellor Rachel Reeves Unveils VAT Cut on Summer Leisure A Surprise CostofLiving Measure SMP Q1 2026 Earnings EPS Surpasses Expectations Stock Rises Slightly ProMIS Neurosciences PMN Gains Momentum as Shares Test Key Resistance Near 1129 Nexxen International Q3 2025 Earnings EPS Surges Past Estimates on Operating Efficiency Capstone Holding Corp CAPS Q4 2025 Earnings Massive EPS Miss Sends Stock Higher A Contradictory Market Reaction RTX Q1 2026 Earnings Solid EPS Beat Driven by Strong Commercial and Defense Demand C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Amid Continued Pipeline Progress MGY Q1 2026 Earnings Modest EPS Beat as Operational Discipline Continues STAG Q1 2026 Earnings Significant EPS Beat Driven by Operational Efficiency Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Per Share Exceeds Expectations Despite Stock Decline